122 related articles for article (PubMed ID: 37904319)
1. Homology modeling, virtual screening, molecular docking, and ADME approaches to identify a potent agent targeting NK2R protein.
Soltani A; Hashemy SI
Biotechnol Appl Biochem; 2024 Feb; 71(1):213-222. PubMed ID: 37904319
[TBL] [Abstract][Full Text] [Related]
2. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
3. Improved ligand-binding- and signaling-competent human NK2R yields in yeast using a chimera with the rat NK2R C-terminus enable NK2R-G protein signaling platform.
Jain AR; Britton ZT; Markwalter CE; Robinson AS
Protein Eng Des Sel; 2019 Dec; 32(10):459-469. PubMed ID: 32400863
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ elevates airway hyper-responsiveness via up-regulation of neurokinin A/neurokinin-2 receptor signaling in a severe asthma model.
Kobayashi M; Ashino S; Shiohama Y; Wakita D; Kitamura H; Nishimura T
Eur J Immunol; 2012 Feb; 42(2):393-402. PubMed ID: 22105467
[TBL] [Abstract][Full Text] [Related]
5. Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.
Madsen JJ; Petersen JE; Christensen DP; Hansen JB; Schwartz TW; Frimurer TM; Olsen OH
J Biol Chem; 2023 Dec; 299(12):105438. PubMed ID: 37944618
[TBL] [Abstract][Full Text] [Related]
6. IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.
Xiang H; Toyoshima Y; Shen W; Wang X; Okada N; Kii S; Sugiyama K; Nagato T; Kobayashi H; Ikeo K; Hashimoto S; Tanino M; Taketomi A; Kitamura H
Cancer Sci; 2022 Aug; 113(8):2513-2525. PubMed ID: 35561088
[TBL] [Abstract][Full Text] [Related]
7. Congenital ablation of
Torres E; Velasco I; Franssen D; Heras V; Gaytan F; Leon S; Navarro VM; Pineda R; Candenas ML; Romero-Ruiz A; Tena-Sempere M
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E496-E511. PubMed ID: 33427049
[TBL] [Abstract][Full Text] [Related]
8. Distribution pattern of tachykinin NK2 receptors in human colon: involvement in the regulation of intestinal motility.
Jaafari N; Khomitch-Baud A; Christen MO; Julé Y
J Comp Neurol; 2007 Jul; 503(3):381-91. PubMed ID: 17503489
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous administration of neurokinin receptor subtype-selective agonists on gonadotropin-releasing hormone pulse generator activity and luteinizing hormone secretion in goats.
Yamamura T; Wakabayashi Y; Ohkura S; Navarro VM; Okamura H
J Reprod Dev; 2015; 61(1):20-9. PubMed ID: 25345909
[TBL] [Abstract][Full Text] [Related]
10. NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse.
Vannucchi MG; Faussone-Pellegrini MS
Anat Embryol (Berl); 2000 Sep; 202(3):247-55. PubMed ID: 10994997
[TBL] [Abstract][Full Text] [Related]
11. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin 1 and 2 receptors are involved in PGE
Zhuang J; Gao X; Zhao L; Wei W; Xu F
Respir Physiol Neurobiol; 2022 Dec; 306():103952. PubMed ID: 35905863
[TBL] [Abstract][Full Text] [Related]
13. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Jana S; Singh SK
J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products.
Luo L; Zhong A; Wang Q; Zheng T
Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049884
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor.
Kitamura H; Kobayashi M; Wakita D; Nishimura T
J Immunol; 2012 May; 188(9):4200-8. PubMed ID: 22474018
[TBL] [Abstract][Full Text] [Related]
18. Histamine H
Ghamari N; Zarei O; Reiner D; Dastmalchi S; Stark H; Hamzeh-Mivehroud M
Chem Biol Drug Des; 2019 May; 93(5):832-843. PubMed ID: 30586225
[TBL] [Abstract][Full Text] [Related]
19. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
[TBL] [Abstract][Full Text] [Related]
20. Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor.
Zoffmann S; Bertrand S; Do QT; Bertrand D; Rognan D; Hibert M; Galzi JL
J Neurochem; 2007 Apr; 101(2):506-16. PubMed ID: 17402972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]